Investigators assessed outcomes following discontinuation of statins while maintaining the use of other drugs in older patients receiving polypharmacy.
For patients with established atherosclerotic cardiovascular disease, there is no significant difference in cardiovascular events or major bleeding for those receiving 81 mg or 325 mg of aspirin daily.
Austrian researchers investigated the utility of remnant cholesterol as a marker of cardiovascular event risk in coronary artery disease.
Researchers compared a potent antiplatelet inhibition strategy with a less potent inhibition treatment plan in patients with acute coronary syndrome undergoing coronary artery bypass surgery.
Compared with never smokers, current smokers have increased odds of having coronary artery calcification score.
From 2008 to 2017, the rates of cardiovascular diseases declined in the year after MI, with greater reductions seen for women than men.
The use of oversized drug-coated balloons at low pressure was found to be effective in preventing late restenosis in patients with coronary artery disease.
Adults with congenital heart defects are more likely to report cardiovascular comorbidities than those in the general population.
Systematic coronary artery calcium scoring screening and treatment of individuals with a family history of premature coronary artery disease and subclinical disease was found to be more cost-effective than management based on statin treatment thresholds.
A genetic risk score was found to be useful in identifying young individuals at high risk for coronary heart disease who need to undergo coronary artery calcium screening.
